{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:59:54Z","timestamp":1773795594571,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160704"],"award-info":[{"award-number":["82160704"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-025-05464-z","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T10:25:11Z","timestamp":1768213511000},"page":"1401-1414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ANXA1 overexpression promotes B cell acute lymphoblastic leukemia progression and resistance by regulating fatty acid metabolism through PI3K\/Akt signaling"],"prefix":"10.1007","volume":"481","author":[{"given":"Ping","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jishi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"1","key":"5464_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/cas.15583","volume":"114","author":"T Yasuda","year":"2023","unstructured":"Yasuda T, Sanada M, Tsuzuki S et al (2023) Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia. Cancer Sci 114(1):8\u201315","journal-title":"Cancer Sci"},{"issue":"10","key":"5464_CR2","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-018-1043-6","volume":"9","author":"M Xie","year":"2019","unstructured":"Xie M, Yang A, Ma J et al (2019) Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a\/Bim axis and serves as a direct target for resistance reversal. Cell Death Dis 9(10):1013","journal-title":"Cell Death Dis"},{"issue":"5","key":"5464_CR3","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.drudis.2022.01.002","volume":"27","author":"B Micallef","year":"2022","unstructured":"Micallef B, Nistic\u00f2 R, Sarac SB et al (2022) The changing landscape of treatment options in childhood acute lymphoblastic leukaemia. Drug Discov Today 27(5):1483\u20131494","journal-title":"Drug Discov Today"},{"issue":"10230","key":"5464_CR4","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M (2020) Acute lymphoblastic leukaemia. Lancet 395(10230):1146\u20131162","journal-title":"Lancet"},{"issue":"1","key":"5464_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12935-019-0940-9","volume":"19","author":"H Xiao","year":"2019","unstructured":"Xiao H, Ding Y, Gao Y et al (2019) Haploinsufficiency of NR3C1 drives glucocorticoid resistance in adult acute lymphoblastic leukemia cells by down-regulating the mitochondrial apoptosis axis, and is sensitive to Bcl-2 blockage. Cancer Cell Int 19(1):218","journal-title":"Cancer Cell Int"},{"issue":"2","key":"5464_CR6","first-page":"106","volume":"14","author":"G Richard-Carpentier","year":"2019","unstructured":"Richard-Carpentier G, Kantarjian H, Jabbour E (2019) Recent advances in adult acute lymphoblastic leukemia. Curr Hematol Malig R 14(2):106\u2013118","journal-title":"Curr Hematol Malig R"},{"issue":"6","key":"5464_CR7","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1080\/10428194.2021.2020780","volume":"63","author":"KM Sharplin","year":"2022","unstructured":"Sharplin KM, Marks DI (2022) The treatment landscape for relapsed refractory B acute lymphoblastic leukaemia (ALL). Leuk Lymphoma 63(6):1292\u20131301","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"5464_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/leu.2012.372","volume":"27","author":"S Spijkers-Hagelstein JaP, Mimoso Pin","year":"2013","unstructured":"Spijkers-Hagelstein JaP, Mimoso Pinhan\u00e7os S, Schneider P et al (2013) Src kinase-induced phosphorylation of Annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia 27(5):1063\u20131071","journal-title":"Leukemia"},{"issue":"6","key":"5464_CR9","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/leu.2011.388","volume":"26","author":"JaP Spijkers-Hagelstein","year":"2012","unstructured":"Spijkers-Hagelstein JaP, Schneider P, Hulleman E et al (2012) Elevated S100A8\/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia 26(6):1255\u20131265","journal-title":"Leukemia"},{"issue":"3","key":"5464_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s43018-020-0037-3","volume":"1","author":"RJ Autry","year":"2020","unstructured":"Autry RJ, Paugh SW, Carter R et al (2020) Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia. Nat Cancer 1(3):329\u2013344","journal-title":"Nat Cancer"},{"issue":"4","key":"5464_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/CS20150415","volume":"130","author":"Z Boudhraa","year":"2016","unstructured":"Boudhraa Z, Bouchon B, Viallard C et al (2016) Annexin A1 localization and its relevance to cancer. Clin Sci 130(4):205\u2013220","journal-title":"Clin Sci"},{"issue":"10","key":"5464_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105276","volume":"22","author":"C Croissant","year":"2021","unstructured":"Croissant C, Carmeille R, Br\u00e9vart C et al (2021) Annexins and membrane repair dysfunctions in muscular dystrophies. Int J Mol Sci 22(10):5276","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5464_CR13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.bbrc.2018.09.140","volume":"505","author":"C Jia","year":"2018","unstructured":"Jia C, Kong D, Guo Y et al (2018) Enhanced antitumor effect of combination of annexin A1 downregulation and bortezomib treatment in multiple myeloma in vitro and in vivo. Biochem Bioph Res Co 505(3):720\u2013725","journal-title":"Biochem Bioph Res Co"},{"key":"5464_CR14","doi-asserted-by":"publisher","first-page":"1141331","DOI":"10.3389\/fcell.2023.1141331","volume":"11","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhang Z, Guo T et al (2023) Annexin A protein family: focusing on the occurrence, progression and treatment of cancer. Front Cell Dev Biol 11:1141331","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5464_CR15","doi-asserted-by":"publisher","first-page":"17925","DOI":"10.1038\/s41598-017-17622-5","volume":"7","author":"LA Moraes","year":"2017","unstructured":"Moraes LA, Kar S, Foo SL et al (2017) Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment. Sci Rep 7(1):17925","journal-title":"Sci Rep"},{"issue":"5","key":"5464_CR16","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.3892\/mmr.2016.5022","volume":"13","author":"Y Fang","year":"2016","unstructured":"Fang Y, Guan X, Cai T et al (2016) Downregulation of ANXA1 suppresses the biological behavior of human NSCLC cells in vitro. Mol Med Rep 13(5):3858\u20133866","journal-title":"Mol Med Rep"},{"issue":"16","key":"5464_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164106","volume":"13","author":"M-C Chuang","year":"2021","unstructured":"Chuang M-C, Lung J-H, Chen Y-C et al (2021) The association of Annexin A1 and chemosensitivity to Osimertinib in lung cancer cells. Cancers 13(16):4106","journal-title":"Cancers"},{"issue":"1","key":"5464_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-018-0301-4","volume":"38","author":"C Cheng","year":"2018","unstructured":"Cheng C, Geng F, Cheng X et al (2018) Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun 38(1):27","journal-title":"Cancer Commun"},{"issue":"3","key":"5464_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/cancers13030474","volume":"13","author":"Y Matsushita","year":"2021","unstructured":"Matsushita Y, Nakagawa H, Koike K (2021) Lipid metabolism in oncology: why it matters, how to research, and how to treat. Cancers 13(3):474","journal-title":"Cancers"},{"issue":"10","key":"5464_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/13543784.2019.1657825","volume":"28","author":"L Chen","year":"2019","unstructured":"Chen L, Duan Y, Wei H et al (2019) Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1\/2 inhibitors. Expert Opin Investig Drugs 28(10):917\u2013930","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"5464_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7(10):763\u2013777","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"5464_CR22","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/cancers11070948","volume":"11","author":"Z Tracz-Gaszewska","year":"2019","unstructured":"Tracz-Gaszewska Z, Dobrzyn P (2019) Stearoyl-CoA desaturase 1 as a therapeutic target for the treatment of cancer. Cancers 11(7):948","journal-title":"Cancers"},{"issue":"1","key":"5464_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41419-020-03336-6","volume":"12","author":"S Zhao","year":"2021","unstructured":"Zhao S, Cheng L, Shi Y et al (2021) MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS\/AKT\/mTOR signaling pathway. Cell Death Dis 12(1):18","journal-title":"Cell Death Dis"},{"issue":"13","key":"5464_CR24","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/s41388-021-01718-4","volume":"40","author":"H-C Lee","year":"2021","unstructured":"Lee H-C, Ou C-H, Huang Y-C et al (2021) YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer. Oncogene 40(13):2407\u20132421","journal-title":"Oncogene"},{"issue":"1","key":"5464_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41419-020-03331-x","volume":"12","author":"P Liu","year":"2021","unstructured":"Liu P, Ma D, Wang P et al (2021) Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia by inhibiting MSH2. Cell Death Dis 12(1):20","journal-title":"Cell Death Dis"},{"key":"5464_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110610","volume":"130","author":"C Pan","year":"2020","unstructured":"Pan C, Liu P, Ma D et al (2020) Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia. Biomed Pharmacother 130:110610","journal-title":"Biomed Pharmacother"},{"key":"5464_CR27","doi-asserted-by":"publisher","first-page":"708513","DOI":"10.3389\/fcell.2021.708513","volume":"9","author":"C Pan","year":"2021","unstructured":"Pan C, Fang Q, Liu P et al (2021) Mesenchymal stem cells with cancer-associated fibroblast-like phenotype stimulate SDF-1\/CXCR4 axis to enhance the growth and invasion of B-cell acute lymphoblastic leukemia cells through cell-to-cell communication. Front Cell Dev Biol 9:708513","journal-title":"Front Cell Dev Biol"},{"key":"5464_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1274335","volume":"14","author":"ZA Wang","year":"2023","unstructured":"Wang ZA, Wang Y, Li Z et al (2023) Lipid metabolism as a target for cancer drug resistance: progress and prospects. Front Pharmacol 14:1274335","journal-title":"Front Pharmacol"},{"key":"5464_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fcell.2017.00043","volume":"5","author":"M Strickland","year":"2017","unstructured":"Strickland M, Stoll EA (2017) Metabolic reprogramming in glioma. Front Cell Dev Biol 5:43","journal-title":"Front Cell Dev Biol"},{"issue":"17","key":"5464_CR30","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.3390\/molecules25173935","volume":"25","author":"CW Fhu","year":"2020","unstructured":"Fhu CW, Ali A (2020) Fatty acid synthase: an emerging target in cancer. Molecules 25(17):3935","journal-title":"Molecules"},{"issue":"40","key":"5464_CR31","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1038\/s41388-022-02445-0","volume":"41","author":"Y Zhan","year":"2022","unstructured":"Zhan Y, Qiao W, Yi B et al (2022) Dual role of pseudogene TMEM198B in promoting lipid metabolism and immune escape of glioma cells. Oncogene 41(40):4512\u20134523","journal-title":"Oncogene"},{"issue":"1","key":"5464_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11010-019-03644-2","volume":"464","author":"LX Xu","year":"2020","unstructured":"Xu LX, Hao LJ, Ma JQ et al (2020) SIRT3 promotes the invasion and metastasis of cervical cancer cells by regulating fatty acid synthase. Mol Cell Biochem 464(1):11\u201320","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"5464_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang C-H, Li N (2024) Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer 23(1):203","journal-title":"Mol Cancer"},{"issue":"1","key":"5464_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12935-021-02427-4","volume":"22","author":"P Li","year":"2022","unstructured":"Li P, Li L, Li Z et al (2022) Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway. Cancer Cell Int 22(1):7","journal-title":"Cancer Cell Int"},{"issue":"12","key":"5464_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1204-7","volume":"9","author":"J-F Zhu","year":"2018","unstructured":"Zhu J-F, Huang W, Yi H-M et al (2018) Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K\/AKT signaling activation. Cell Death Dis 9(12):1154","journal-title":"Cell Death Dis"},{"issue":"1","key":"5464_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep29660","volume":"6","author":"R Belvedere","year":"2016","unstructured":"Belvedere R, Bizzarro V, Forte G et al (2016) Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway. Sci Rep 6(1):29660","journal-title":"Sci Rep"},{"issue":"5","key":"5464_CR37","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.7150\/jca.52171","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X, Ma W, Li X et al (2021) ANXA1 enhances tumor proliferation and migration by regulating epithelial-mesenchymal transition and IL-6\/JAK2\/STAT3 pathway in papillary thyroid carcinoma. J Cancer 12(5):1295\u20131306","journal-title":"J Cancer"},{"key":"5464_CR38","doi-asserted-by":"publisher","first-page":"101516","DOI":"10.1016\/j.tranon.2022.101516","volume":"25","author":"Q Chen","year":"2022","unstructured":"Chen Q, Lai Q, Jiang Y et al (2022) Anlotinib exerts potent antileukemic activities in ph chromosome negative and positive B-cell acute lymphoblastic leukemia via perturbation of PI3K\/AKT\/mTOR pathway. Transl Oncol 25:101516","journal-title":"Transl Oncol"},{"issue":"1","key":"5464_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG et al (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6(1):425","journal-title":"Signal Transduct Target Ther"},{"key":"5464_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231710132","author":"S Stanciu","year":"2022","unstructured":"Stanciu S, Ionita-Radu F, Stefani C et al (2022) Targeting PI3K\/AKT\/mTOR signaling pathway in pancreatic cancer: from molecular to clinical aspects. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231710132","journal-title":"Int J Mol Sci"},{"key":"5464_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162508","author":"K Zhu","year":"2022","unstructured":"Zhu K, Wu Y, He P et al (2022) PI3K\/AKT\/mTOR-targeted therapy for breast cancer. Cells. https:\/\/doi.org\/10.3390\/cells11162508","journal-title":"Cells"},{"issue":"1","key":"5464_CR42","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12935-022-02676-x","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Noie Alamdari A, Noee Alamdari Y et al (2022) Role of PI3K\/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers. Cancer Cell Int 22(1):254","journal-title":"Cancer Cell Int"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05464-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:02:12Z","timestamp":1773781332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05464-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["5464"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05464-z","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}